We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 19

Pfizer Runs Afoul of Feds with Patient Assistance Program Payments
  • FisherBroyles LLP
  • USA
  • May 30 2018

The U.S. Department of Justice announced late last week that it had settled with Pfizer, Inc. (Pfizer) over allegations that the company had


FDA Issues Draft Guidance on Bulk Compound Drug Substances
  • FisherBroyles LLP
  • USA
  • March 27 2018

In January of this year, and in response to concerns over the risks associated with the use of non-FDA approved, compounded drugs (particularly in


HHS-OIG Issues Recommendations to Medicare on Reducing Fraud and Waste Related to Chiropractic Care
  • FisherBroyles LLP
  • USA
  • February 27 2018

Last week the Health and Human Services Office of Inspector General (OIG) issued an OIG Portfolio entitled, "Medicare Needs Better Controls to Prevent


Nationwide Dialysis Provider Settles Patient Privacy Breach Allegations for $3.5 Million
  • FisherBroyles LLP
  • USA
  • February 5 2018

Late last week, Fresenius Medical Care (FMC), a dialysis provider with nationwide coverage that also operates a number of urgent care centers and labs


Patient Assistance Charity Loses Protection from Kickback Liability Office of Inspector General Revokes Advisory Opinion
  • FisherBroyles LLP
  • USA
  • December 4 2017

In an unprecedented action, the U.S. Department of Health and Human Services Office of Inspector General (OIG) has revoked an Advisory Opinion that


Health Care Fraud is a Priority for the DOJ: Notes from the ABA’s Institute on Health Care Fraud
  • FisherBroyles LLP
  • USA
  • May 23 2017

On May 18, 2017, Acting Assistant Attorney General Kenneth A. Blanco of the Criminal Division of the Department of Justice (DOJ) addressed attendees


HHS Office of Inspector General Issues Annual Report on MFCU Activities
  • FisherBroyles LLP
  • USA
  • May 22 2017

The U.S. Department of Health and Human Services, Office of Inspector General (HHS-OIG) recently released its Medicaid Fraud Control Units Fiscal Year


Lab Giant Quest Diagnostics to Pay $6 Million to Settle Kickback Allegations
  • FisherBroyles LLP
  • USA
  • May 8 2017

The U.S. Justice Department announced in a recent release that medical laboratory giant Quest Diagnostics (Quest) has agreed to pay $6 million to


Wireless Health Services Provider Agrees to $2.5 Million Settlement for HIPAA Disclosures
  • FisherBroyles LLP
  • USA
  • May 2 2017

In a first-of-its-kind settlement for a wireless health care services provider, CardioNet, a Pennsylvania-based telemetry company, has agreed to pay


Measuring the Effectiveness of Your Compliance Program: OIG Issues Guide Describing Elements and Metrics
  • FisherBroyles LLP
  • USA
  • April 3 2017

On March 27, 2017, the U.S. Department of Health and Human Services, Office of Inspector General (HHSOIG) released a 53-page document, "Measuring